PATZ1 and glioblastoma: Further experiments are ongoing in our laboratory to explore the possibility of a direct role of PATZ1 on the CXCR4 promoter in GBM as well as in other cancer-derived cell lines, where PATZ1 appears involved in counteracting EMT.